XCUR - EXICURE, INC.
4.15
0.160 3.855%
Share volume: 6,937
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$3.99
0.16
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 06-17-2024 | 08-13-2024 | 11-14-2024 | 03-18-2025 | 06-27-2025 | 08-08-2025 | 11-07-2025 | |
| Total revenue | 500.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 500.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 1.336 M | 1.235 M | 1.434 M | 1.444 M | 3.025 M | 2.449 M | 2.387 M | |
| Selling general and admin | 1.336 M | 1.235 M | 1.434 M | 1.444 M | 2.217 M | 1.514 M | 1.499 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 808.000 K | 935.000 K | 888.000 K | |
| Total expenses | 1.336 M | 1.235 M | 2.572 M | 7.589 M | -2.949 M | 2.509 M | 2.391 M | |
| -7.56% | 108.26% | 195.06% | -138.86% | 185.08% | -4.70% | |||
| Operating income | -836.000 K | -1.235 M | -2.572 M | -7.589 M | 2.949 M | -2.509 M | -2.391 M | |
| Ebit | -836.000 K | -598.000 K | -1.072 M | -7.182 M | 2.978 M | -2.677 M | -2.493 M | |
| Pretax income | -829.000 K | -600.000 K | -1.083 M | -7.181 M | 3.010 M | -2.621 M | -2.437 M | |
| -27.62% | 80.50% | 563.07% | -141.92% | -187.08% | -7.02% | |||
| Income tax | 0.000 | 0.000 | 8.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -829.000 K | -600.000 K | -1.091 M | -7.181 M | 3.010 M | -2.621 M | -2.437 M | |
| 27.62% | -81.83% | -558.20% | 141.92% | -187.08% | 7.02% |